Case report: Novel compound heterozygous

autoinflammatory diseases (AID) case report interleukin-1 interleukin-1 receptor antagonist (IL-1 ra) whole-genome sequencing (WGS)

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 03 02 2024
accepted: 04 03 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: epublish

Résumé

Undiagnosed monogenic diseases represent a challenging group of human conditions highly suspicious to have a genetic origin, but without conclusive evidences about it. We identified two brothers born prematurely from a non-consanguineous healthy couple, with a neonatal-onset, chronic disease characterized by severe skin and bone inflammatory manifestations and a fatal outcome in infancy. We conducted DNA and mRNA analyses in the patients' healthy relatives to identify the genetic cause of the patients' disease. DNA analyses were performed by both Sanger and next-generation sequencing, which identified two novel heterozygous

Identifiants

pubmed: 38646532
doi: 10.3389/fimmu.2024.1381447
pmc: PMC11026629
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1381447

Informations de copyright

Copyright © 2024 Urbaneja, Bonet, Solis-Moruno, Mensa-Vilaro, de Landazuri, Tormo, Lara, Plaza, Fabregat, Yagüe, Casals and Arostegui.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Elena Urbaneja (E)

Department of Immunology and Pediatric Rheumatology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Nuria Bonet (N)

Genomics Core Facility, Departament de Medicina i Ciències de la Vida (MELIS), Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.

Manuel Solis-Moruno (M)

Genomics Core Facility, Departament de Medicina i Ciències de la Vida (MELIS), Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.

Anna Mensa-Vilaro (A)

Department of Immunology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Iñaki Ortiz de Landazuri (IO)

Department of Immunology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Marc Tormo (M)

Genomics Core Facility, Departament de Medicina i Ciències de la Vida (MELIS), Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.
Scientific Computing Core Facility, Departament de Medicina i Ciències de la Vida (MELIS), Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.

Rocio Lara (R)

Department of Immunology, Hospital Clínic, Barcelona, Spain.

Susana Plaza (S)

Department of Immunology, Hospital Clínic, Barcelona, Spain.

Virginia Fabregat (V)

Department of Immunology, Hospital Clínic, Barcelona, Spain.

Jordi Yagüe (J)

Department of Immunology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
School of Medicine, Universitat de Barcelona, Barcelona, Spain.

Ferran Casals (F)

Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.
Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Juan I Arostegui (JI)

Department of Immunology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
School of Medicine, Universitat de Barcelona, Barcelona, Spain.

Classifications MeSH